Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (45)
Pyeong Seok Choi, Jun Young Lee, Seung Dae Yang & Jeong Hoon Park. (2021) Biological behavior of nanoparticles with Zr-89 for cancer targeting based on their distinct surface composition. Journal of Materials Chemistry B 9:39, pages 8237-8245.
Crossref
Crossref
Vishakha Tambe, Umesh Kathar, Nidhi Raval, Kuldeep Rajpoot, Satish Shilpi, Kapil Khatri & Rakesh Kumar Tekade. 2021. Biopharmaceutics and Pharmacokinetics Considerations. Biopharmaceutics and Pharmacokinetics Considerations
617
641
.
Michael S. Valic, Michael Halim, Pamela Schimmer & Gang Zheng. (2020) Guidelines for the experimental design of pharmacokinetic studies with nanomaterials in preclinical animal models. Journal of Controlled Release 323, pages 83-101.
Crossref
Crossref
Massimo Mischi, Simona Turco, Osama I. Soliman, Folkert J. ten Cate, Hessel Wijkstra & Ivo SchootsMassimo Mischi, Simona Turco, Osama I. Soliman, Folkert J. ten Cate, Hessel Wijkstra & Ivo Schoots. 2018. Quantification of Contrast Kinetics in Clinical Imaging. Quantification of Contrast Kinetics in Clinical Imaging
131
184
.
Allison N. Schorzman, Andrew T. Lucas, John R. Kagel & William C. Zamboni. 2018. Targeted Drug Delivery. Targeted Drug Delivery
201
228
.
Terry P. Kenakin. 2017. Pharmacology in Drug Discovery and Development. Pharmacology in Drug Discovery and Development
193
224
.
Sandrine Marchand, Alexia Chauzy, Claire Dahyot-Fizelier & William Couet. (2016) Microdialysis as a way to measure antibiotics concentration in tissues. Pharmacological Research 111, pages 201-207.
Crossref
Crossref
Ping Liu, Runlin Yang, Donghui Pan, Yuping Xu, Chen Zhu, Qing Xu, Lizhen Wang, Junjie Yan, Xiaotian Li & Min Yang. (2015) An investigation on the anti-tumor properties of FSH33-53-Lytic. Journal of Radioanalytical and Nuclear Chemistry 307:1, pages 89-97.
Crossref
Crossref
Hui Wang, Li Liu, Yang Lu, Pan Pan, Jacob M. Hooker, Joanna S. Fowler & Peter J. Tonge. (2015) Radiolabelling and positron emission tomography of PT70, a time-dependent inhibitor of InhA, the Mycobacterium tuberculosis enoyl-ACP reductase. Bioorganic & Medicinal Chemistry Letters 25:21, pages 4782-4786.
Crossref
Crossref
Hui Wang, Yang Lu, Li Liu, Sung Won Kim, Jacob M. Hooker, Joanna S. Fowler & Peter J. Tonge. (2014) Radiosynthesis and biological evaluation of a novel enoyl-ACP reductase inhibitor for Staphylococcus aureus. European Journal of Medicinal Chemistry 88, pages 66-73.
Crossref
Crossref
Daniel H. Johnson, Laura E. Via, Peter Kim, Dominick Laddy, Chuen-Yen Lau, Edward A. Weinstein & Sanjay Jain. (2014) Nuclear imaging: A powerful novel approach for tuberculosis. Nuclear Medicine and Biology 41:10, pages 777-784.
Crossref
Crossref
Austin J. Combest & William C. Zamboni. 2014. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics
477
498
.
Markus Zeitlinger, Sandrine Marchand, William Couet, Aline Barth & Hartmut Derendorf. 2013. Microdialysis in Drug Development. Microdialysis in Drug Development
103
126
.
E. A. Weinstein, L. Liu, A. A. Ordonez, H. Wang, J. M. Hooker, P. J. Tonge & S. K. Jain. (2012)
Noninvasive Determination of 2-[
18
F]-Fluoroisonicotinic Acid Hydrazide Pharmacokinetics by Positron Emission Tomography in Mycobacterium tuberculosis-Infected Mice
. Antimicrobial Agents and Chemotherapy 56:12, pages 6284-6290.
Crossref
Crossref
Terry P. Kenakin. 2012. Pharmacology in Drug Discovery. Pharmacology in Drug Discovery
155
183
.
Qingyu Zhou & James M. Gallo. 2011. Applications of Microdialysis in Pharmaceutical Science. Applications of Microdialysis in Pharmaceutical Science
403
430
.
Claudia C. Wagner & Oliver Langer. (2011) Approaches using molecular imaging technology — use of PET in clinical microdose studies. Advanced Drug Delivery Reviews 63:7, pages 539-546.
Crossref
Crossref
Jayesh Dhanani, Jason A. Roberts, Michelle Chew, Jeffrey Lipman, Robert J. Boots, David L. Paterson & John F. Fraser. (2010) Antimicrobial chemotherapy and lung microdialysis: a review. International Journal of Antimicrobial Agents 36:6, pages 491-500.
Crossref
Crossref
Thomas J. Spencer, Bertha K. Madras, Ali A. Bonab, Darin D. Dougherty, Allison Clarke, Tara Mirto, Jessica Martin & Alan J. Fischman. (2010) A Positron Emission Tomography Study Examining The Dopaminergic Activity of Armodafinil in Adults Using [11C]Altropane and [11C]Raclopride. Biological Psychiatry 68:10, pages 964-970.
Crossref
Crossref
Erik H. F. Wong, Frank Yocca, Mark A. Smith & Chi-Ming Lee. (2010) Challenges and opportunities for drug discovery in psychiatric disorders: the drug hunters' perspective. The International Journal of Neuropsychopharmacology 13:09, pages 1269-1284.
Crossref
Crossref
Graham LappinClaudia C WagnerOliver Langer & Nico van de Merbel. (2009) New ultrasensitive detection technologies and techniques for use in microdosing studies. Bioanalysis 1:2, pages 357-366.
Crossref
Crossref
Stephanie H. Kim, Karl G. Csaky, Nam Sun Wang & Robert J. Lutz. (2007) Drug Elimination Kinetics Following Subconjunctival Injection Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Pharmaceutical Research 25:3, pages 512-520.
Crossref
Crossref
Martin Bauer, Claudia Christina Wagner & Oliver Langer. (2008) Microdosing Studies in Humans. Drugs in R & D 9:2, pages 73-81.
Crossref
Crossref
WC ZAMBONI. 2007. Artificial Cells, Cell Engineering and Therapy. Artificial Cells, Cell Engineering and Therapy
469
501
.
Chi-Ming Lee & Lars Farde. (2006) Using positron emission tomography to facilitate CNS drug development. Trends in Pharmacological Sciences 27:6, pages 310-316.
Crossref
Crossref
Martin Brunner & Oliver Langer. (2006) Microdialysis versus other techniques for the clinical assessment of in vivo tissue drug distribution. The AAPS Journal 8:2, pages E263-E271.
Crossref
Crossref
Haihao Sun, Jerry M. Collins, Thomas J. Mangner, Otto Muzik & Anthony F. Shields. (2005) Imaging the pharmacokinetics of [F-18]FAU in patients with tumors: PET studies. Cancer Chemotherapy and Pharmacology 57:3, pages 343-348.
Crossref
Crossref
M Brunner & O Langer. (2006) Microdialysis Versus Other Techniques for the Clinical Assessment of In Vivo Tissue Drug Distribution. The AAPS Journal 08:02, pages E263.
Crossref
Crossref
Martin Brunner & Markus Müller. 2006. Handbook of Microdialysis - Methods, Applications and Perspectives. Handbook of Microdialysis - Methods, Applications and Perspectives
625
644
.
Y.-X. J. Wang. (2005) Medical imaging in pharmaceutical clinical trials: what radiologists should know. Clinical Radiology 60:10, pages 1051-1057.
Crossref
Crossref
Qingyu Zhou & James M. Gallo. (2005) In vivo microdialysis for PK and PD studies of anticancer drugs. The AAPS Journal 7:3, pages E659-E667.
Crossref
Crossref
Homer H. Pien, Alan J. Fischman, James H. Thrall & A.Gregory Sorensen. (2005) Using imaging biomarkers to accelerate drug development and clinical trials. Drug Discovery Today 10:4, pages 259-266.
Crossref
Crossref
Christian Joukhadar & Markus M??ller. (2005) Microdialysis. Clinical Pharmacokinetics 44:9, pages 895-913.
Crossref
Crossref
Mats Bergström & Bengt Långström. 2005. Imaging in Drug Discovery and Early Clinical Trials. Imaging in Drug Discovery and Early Clinical Trials
279
317
.
Martin Brunner, Oliver Langer, Georg Dobrozemsky, Ulrich Müller, Markus Zeitlinger, Markus Mitterhauser, Wolfgang Wadsak, Robert Dudczak, Kurt Kletter & Markus Müller. (2004)
[
18
F]Ciprofloxacin, a New Positron Emission Tomography Tracer for Noninvasive Assessment of the Tissue Distribution and Pharmacokinetics of Ciprofloxacin in Humans
. Antimicrobial Agents and Chemotherapy 48:10, pages 3850-3857.
Crossref
Crossref
Markus Müller, Amparo dela Peña & Hartmut Derendorf. (2004) Issues in Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents: Distribution in Tissue. Antimicrobial Agents and Chemotherapy 48:5, pages 1441-1453.
Crossref
Crossref
William C. Zamboni. 2004. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics
307
326
.
Ping Liu & Hartmut Derendorf. (2003) Antimicrobial tissue concentrations. Infectious Disease Clinics of North America 17:3, pages 599-613.
Crossref
Crossref
Lisa A. Hammond, Louis Denis, Umber Salman, Paul Jerabek, Charles R. ThomasJr.Jr. & John G. Kuhn. (2003) Positron emission tomography (PET): Expanding the horizons of oncology drug development. Investigational New Drugs 21:3, pages 309-340.
Crossref
Crossref
Oliver Langer, Markus Mitterhauser, Wolfgang Wadsak, Martin Brunner, Ulrich Müller, Kurt Kletter & Markus Müller. (2003) A general method for the fluorine-18 labelling of fluoroquinolone antibiotics. Journal of Labelled Compounds and Radiopharmaceuticals 46:8, pages 715-727.
Crossref
Crossref
Oliver Langer, Markus Mitterhauser, Martin Brunner, Markus Zeitlinger, Wolfgang Wadsak, Bernhard X. Mayer, Kurt Kletter & Markus M?ller. (2003) Synthesis of fluorine-18-labeled ciprofloxacin for PET studies in humans. Nuclear Medicine and Biology 30:3, pages 285-291.
Crossref
Crossref
M. P. Goldberg. 2002. CNS Neuroprotection. CNS Neuroprotection
361
386
.
Paul M. Matthews, Marenza Wylezinska & Tom Cadoux-Hudson. (2001) NOVEL APPROACHES TO IMAGING BRAIN TUMORS. Hematology/Oncology Clinics of North America 15:4, pages 609-630.
Crossref
Crossref
Simon R. Cherry. (2001) Fundamentals of Positron Emission Tomography and Applications in Preclinical Drug Development. The Journal of Clinical Pharmacology 41:5, pages 482-491.
Crossref
Crossref
Markus Müller. (2000) Microdialysis in clinical drug delivery studies. Advanced Drug Delivery Reviews 45:2-3, pages 255-269.
Crossref
Crossref